TBPH Financials
Theravance Biopharma Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$861.45M
P/E Ratio
7.5
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$18.75M
Gross Profit
-
Operating Income
-
Net Income
$-15.53M
EPS (Diluted)
$-0.31
Balance Sheet Highlights
Total Assets
$354.16M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$37.80M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-11.54M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
104.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is TBPH revenue?
TBPH's most recent quarterly revenue was $18.75M. Annual revenue can be calculated by summing the four most recent quarters.
Is TBPH profitable?
TBPH reported a loss of $15.53M in the most recent quarter. The net profit margin is 104.3%.
What is TBPH market cap?
TBPH has a market capitalization of $861.45M, making it a small-cap stock.
Does TBPH have debt?
View TBPH's balance sheet for debt information.
What is TBPH cash flow?
Cash flow data is available in the full financial statements.